Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 217,475,711 papers from all fields of science
Search
Sign In
Create Free Account
DAPK1 gene
Known as:
death associated protein kinase 1
, DAPK
, Death-Associated Protein Kinase 1 Gene
Expand
This gene is involved in pro-apoptotic regulation.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
8 relations
DAPK1 protein, human
Phosphorylation
Positive Regulation of Apoptosis
Serine/Threonine Phosphorylation
Expand
Narrower (1)
DAPK1 wt Allele
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4.
Hsin-Yi Chen
,
Yu-min Lin
,
+10 authors
Ruey-Hwa Chen
Cancer Research
2012
Corpus ID: 6108658
Metastasis is the major cause of poor prognosis in colorectal cancer (CRC), and increasing evidence supports the contribution of…
Expand
Highly Cited
2010
Highly Cited
2010
DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in Stroke
Weihong Tu
,
Xin Xu
,
+11 authors
Y. Lu
Cell
2010
Corpus ID: 7888986
Highly Cited
2010
Highly Cited
2010
Linking ER Stress to Autophagy: Potential Implications for Cancer Therapy
T. Verfaillie
,
M. Salazar
,
G. Velasco
,
P. Agostinis
International Journal of Cell Biology
2010
Corpus ID: 12837330
Different physiological and pathological conditions can perturb protein folding in the endoplasmic reticulum, leading to a…
Expand
Highly Cited
2009
Highly Cited
2009
DAP‐kinase‐mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl‐XL and induction of autophagy
Einat Zalckvar
,
H. Berissi
,
+6 authors
A. Kimchi
EMBO Reports
2009
Corpus ID: 35594521
Autophagy, an evolutionarily conserved process, has functions both in cytoprotective and programmed cell death mechanisms. Beclin…
Expand
Review
2002
Review
2002
CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future
M. Esteller
Oncogene
2002
Corpus ID: 12687785
We have come a long way since the first reports of the existence of aberrant DNA methylation in human cancer. Hypermethylation of…
Expand
Highly Cited
2002
Highly Cited
2002
Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features.
R. Maruyama
,
S. Toyooka
,
+7 authors
A. Gazdar
Clinical Cancer Research
2002
Corpus ID: 11493534
PURPOSE We investigated the aberrant methylation profile of prostate cancers and correlated the data with clinical findings…
Expand
Highly Cited
2001
Highly Cited
2001
A gene hypermethylation profile of human cancer.
M. Esteller
,
M. Esteller
,
P. Corn
,
S. Baylin
,
J. Herman
Cancer Research
2001
Corpus ID: 26030990
We are in an era where the potential exists for deriving comprehensive profiles of DNA alterations characterizing each form of…
Expand
Highly Cited
2001
Highly Cited
2001
Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
S. Zöchbauer-Müller
,
K. Fong
,
A. Virmani
,
J. Geradts
,
A. Gazdar
,
J. Minna
Cancer Research
2001
Corpus ID: 13318161
Aberrant methylation of CpG islands acquired in tumor cells in promoter regions is one method for loss of gene function. We…
Expand
Highly Cited
2001
Highly Cited
2001
Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features.
R. Maruyama
,
S. Toyooka
,
+9 authors
A. Gazdar
Cancer Research
2001
Corpus ID: 5907599
We investigated the aberrant promoter methylation profile of bladder cancers and correlated the data with clinicopathological…
Expand
Review
2001
Review
2001
Molecular genetics of small cell lung carcinoma.
I. Wistuba
,
I. Wistuba
,
A. Gazdar
,
A. Gazdar
,
J. Minna
,
J. Minna
Seminars in Oncology
2001
Corpus ID: 769297
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE